SCHEMBL15020327

SCHEMBL15020327

CCCC1=C(O)C(=Nc2ccc(N(CC)C(C)C)cc2)C=C(Nc2ccc(N(CC)C(C)C)cc2)C1=O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 7/20 0.34
▸ MAPT P10636 6/20 0.34
▸ KMT2A Q03164 5/20 0.34
▸ MEN1 O00255 4/20 0.34
▸ APAF1 O14727 3/20 0.33
▸ NPC1 O15118 2/20 0.33
▸ HSP90AA1 P07900 2/20 0.33
▸ POLB P06746 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ ALDH1A1 P00352 10/20 0.33
▸ LMNA P02545 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ P2RX3 P56373 2/20 0.33
▸ MCL1 Q07820 3/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ HPGD P15428 1/20 0.31
▸ MAPK1 P28482 1/20 0.30
▸ GPR55 Q9Y2T6 1/20 0.30
▸ KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15020326 1.00 L3MBTL1 (0.34) L3MBTL1MAPTKMT2AMEN1APAF1
SCHEMBL15020050 0.88 ALDH1A1 (0.33) L3MBTL1MAPTKMT2AMEN1ALDH1A1
SCHEMBL15020051 0.88 ALDH1A1 (0.33) L3MBTL1MAPTKMT2AMEN1ALDH1A1
SCHEMBL16426662 0.85 RAB9A (0.42) L3MBTL1MAPTKMT2AMEN1APAF1
SCHEMBL15020256 0.84 IDO1 (0.37) L3MBTL1MAPTKMT2AMEN1APAF1
SCHEMBL15020258 0.84 IDO1 (0.37) L3MBTL1MAPTKMT2AMEN1APAF1
SCHEMBL17253312 0.83 ALDH1A1 (0.35) L3MBTL1MAPTKMT2AMEN1APAF1
SCHEMBL16426665 0.83 RAB9A (0.34) L3MBTL1MAPTKMT2AMEN1APAF1
SCHEMBL16413878 0.81 DNM1 (0.37) L3MBTL1MAPTKMT2AMEN1APAF1
SCHEMBL16413881 0.81 DNM1 (0.37) L3MBTL1MAPTKMT2AMEN1APAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150027483-A1 TRI-AROMATIC AZOMETHINE DIRECT DYES COMPRISING AT LEAST ONE UNIT DERIVED FROM RESORCINOL, DYEING COMPOSITION, METHOD AND USE L'OREAL (FR) 2015-01-29 — — US claimed
EP-2791251-A1 TRI-AROMATIC AZOMETHINE DIRECT DYES COMPRISING AT LEAST ONE UNIT DERIVED FROM RESORCINOL, DYEING COMPOSITION, METHOD AND USE L'OREAL (FR) 2014-10-22 — — EP claimed
WO-2013087772-A1 TRI-AROMATIC AZOMETHINE DIRECT DYES COMPRISING AT LEAST ONE UNIT DERIVED FROM RESORCINOL, DYEING COMPOSITION, METHOD AND USE L'OREAL (FR) 2013-06-20 — — WO claimed
US-9439844-B2 Tri-aromatic azomethine direct dyes comprising at least one unit derived from resorcinol, dyeing composition, method and use L'OREAL (FR) 2016-09-13 — — US disclosed
US-20150027483-A1 TRI-AROMATIC AZOMETHINE DIRECT DYES COMPRISING AT LEAST ONE UNIT DERIVED FROM RESORCINOL, DYEING COMPOSITION, METHOD AND USE L'OREAL (FR) 2015-01-29 — — US disclosed
EP-2791251-A1 TRI-AROMATIC AZOMETHINE DIRECT DYES COMPRISING AT LEAST ONE UNIT DERIVED FROM RESORCINOL, DYEING COMPOSITION, METHOD AND USE L'OREAL (FR) 2014-10-22 — — EP disclosed
WO-2013087772-A1 TRI-AROMATIC AZOMETHINE DIRECT DYES COMPRISING AT LEAST ONE UNIT DERIVED FROM RESORCINOL, DYEING COMPOSITION, METHOD AND USE L'OREAL (FR) 2013-06-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150027483-A1 TRI-AROMATIC AZOMETHINE DIRECT DYES COMPRISING AT LEAST ONE UNIT DERIVED FROM RESORCINOL, DYEING COMPOSITION, METHOD AND USE KRT18, IK, MKI67 L3MBTL1 4835/4885MAPT 132/4885KMT2A 948/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback